From: The impact of repeated marathon running on cardiovascular function in the aging population
Echo parameters | Baseline | Post-race | Follow-up | p-value |
---|---|---|---|---|
 LV parameters (2D TTE)  | ||||
LVEDD (mm) | 50 ± 3 | 51 ± 5 | 50 ± 4 | 0.93 |
LVESD (mm) | 33 ± 5 | 34 ± 4 | 32 ± 5 | 0.82 |
LVEDV (ml) | 114 ± 12 | 110 ± 10 | 112 ± 11 | 0.72 |
LVESV (ml) | 39 ± 11 | 38 ± 13 | 40 ± 11 | 0.77 |
IVS (mm) | 9 ± 2 | 9 ± 1 | 9 ± 2 | 0.82 |
PWT (mm) | 9 ± 1 | 8 ± 2 | 9 ± 2 | 0.71 |
LVEF (%) | 63 ± 4 | 62 ± 6 | 64 ± 3 | 0.79 |
LV mass/BSA (g/m2) | 102 ± 11 | 103 ± 15 | 99 ± 17 | 0.49 |
 LA parameters (2D TTE)  | ||||
LA diameter (mm) | 36 ± 4 | 37 ± 3 | 36 ± 5 | 0.66 |
LA volume (ml) | 42 ± 11 | 44 ± 13 | 40 ± 13 | 0.44 |
 RA and RV parameters (2D TTE)  | ||||
RA volume (ml) | 37 ± 12 | 61 ± 12 | 31 ± 13 | 0.01* |
RVEDD (mm) | 27 ± 3 | 45 ± 2 | 32 ± 4 | 0.02* |
RV FAC (%) | 48 ± 3 | 29 ± 6 | 49 ± 4 | 0.01* |
TAPSE (mm) | 2.3 ± 0.4 | 1.4 ± 0.2 | 2.1 ± 0.3 | 0.02* |